Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Approved Flu Vaccine in Children.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children, males and females, healthy or at high risk of complications from influenza, between ≥6 months to \<72 months of age~* Documented consent provided by the subject's parent(s)/legal guardian(s)~* Subjects and/or subject's parent(s)/legal guardian(s) able to comply with all study procedures.~Exclusion Criteria:~* Children with history of allergy to vaccine components.~* Additional eligibility criteria may be discussed by contacting the site

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 71 Months
- Healthy Volunteers: t

Study Arms:
- aQIV (Type: EXPERIMENTAL): flu vaccine
- non-adjuvanted comparator (Type: ACTIVE_COMPARATOR): flu vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).